Suppr超能文献

比较三种不同技术对KRAS基因第1外显子的突变分析:时间温度梯度电泳、恒定变性剂毛细管电泳和等位基因特异性聚合酶链反应。

Mutation analyses of KRAS exon 1 comparing three different techniques: temporal temperature gradient electrophoresis, constant denaturant capillary electrophoresis and allele specific polymerase chain reaction.

作者信息

Bjørheim J, Lystad S, Lindblom A, Kressner U, Westring S, Wahlberg S, Lindmark G, Gaudernack G, Ekstrøm P, Røe J, Thilly W G, Børresen-Dale A L

机构信息

Department of Immunology, Norwegian Radium Hospital, Oslo, Norway.

出版信息

Mutat Res. 1998 Jul 17;403(1-2):103-12. doi: 10.1016/s0027-5107(98)00057-8.

Abstract

Mutations in the KRAS gene is a key event in the carcinogenesis of many human cancers and may serve as a diagnostic marker and a target for therapeutic intervention. In this study we have applied three different techniques for mutation detection of KRAS exon 1 mutations: Allele specific polymerase chain reaction (AS-PCR), temporal temperature gradient electrophoresis (TTGE) and constant denaturant capillary electrophoresis (CDCE). Samples from 191 sporadic colon carcinomas were analyzed. AS-PCR were performed with oligonucleotides specific for know mutations in codon 12 and 13 of the KRAS gene. In TTGE analyses, linear ramping of the temperature were performed during electrophoresis in a constant denaturant gel. CDCE analyses were performed using fluorescin labeled PCR-products. Separation was achieved under constant denaturing conditions using high temperature in a gel-filled capillary followed by laser detection. A mutated KRAS gene was found in 42/191 (22.0%) of the samples using AS-PCR, in 62/191 (32.5%) using TTGE and in 66/191 (34.6%) of the samples using CDCE. In the TTGE and CDCE analyses the sequence of the mutant were determined by comparing the electrophoretic pattern to that of known mutations or by mixing the sample with known mutations prior to reanalysis. In a titration experiment mixing mutant and wild-type alleles prior to PCR, the sensitivity for mutation detection was shown to be 10(-2) for TTGE and under optimized conditions 10(-3) for CDCE.

摘要

KRAS基因的突变是许多人类癌症发生过程中的关键事件,可作为诊断标志物和治疗干预靶点。在本研究中,我们应用了三种不同技术检测KRAS基因第1外显子的突变:等位基因特异性聚合酶链反应(AS-PCR)、温度梯度凝胶电泳(TTGE)和恒变性毛细管电泳(CDCE)。对191例散发性结肠癌样本进行了分析。AS-PCR采用针对KRAS基因第12和13密码子已知突变的寡核苷酸进行。在TTGE分析中,在恒变性凝胶中电泳时对温度进行线性递增。CDCE分析使用荧光素标记的PCR产物。在恒变性条件下,于填充凝胶的毛细管中采用高温进行分离,随后进行激光检测。使用AS-PCR在42/191(22.0%)的样本中发现了KRAS基因突变,使用TTGE在62/191(32.5%)的样本中发现了该突变,使用CDCE在66/191(34.6%)的样本中发现了该突变。在TTGE和CDCE分析中,通过将电泳图谱与已知突变的图谱进行比较,或在重新分析前将样本与已知突变混合,来确定突变体的序列。在PCR前混合突变体和野生型等位基因的滴定实验中,TTGE检测突变的灵敏度为10(-2),在优化条件下CDCE的灵敏度为10(-3)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验